SC
CPRX

Steven Cohen’s Catalyst Pharmaceutical CPRX Stock Holding History

Steven Cohen’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55M Sell
176,560
-249,305
-59% -$7.36M 0.01% 1689
2026
Q1 		$10.5M Buy
+425,865
New +$10.1M 0.01% 1212
2024
Q3 		– Sell
-618,296
Closed -$9.58M – 2039
2024
Q2 		$9.58M Buy
618,296
+200,370
+48% +$3.12M 0.03% 632
2024
Q1 		$6.66M Sell
417,926
-78,665
-16% -$1.19M 0.02% 874
2023
Q4 		$8.35M Buy
496,591
+300,280
+153% +$4.1M 0.02% 743
2023
Q3 		$2.29M Buy
+196,311
New +$2.63M 0.01% 1105
2023
Q2 		– Sell
-1,470
Closed -$24.4K – 2258
2023
Q1 		$24.4K Buy
+1,470
New +$24.3K ﹤0.01% 1942
2020
Q4 		– Sell
-50,000
Closed -$149K – 944
2020
Q3 		$149K Buy
+50,000
New +$196K ﹤0.01% 878
2017
Q2 		– Sell
-877,266
Closed -$1.71M – 853
2017
Q1 		$1.71M Sell
877,266
-1,395,550
-61% -$1.78M 0.01% 685
2016
Q4 		$2.39M Sell
2,272,816
-94,148
-4% -$108K 0.02% 545
2016
Q3 		$2.58M Hold
2,366,964
– – 0.02% 530
2016
Q2 		$1.68M Buy
2,366,964
+103,388
+5% +$83.3K 0.01% 580
2016
Q1 		$2.65M Sell
2,263,576
-13,347
-0.6% -$20.7K 0.02% 531
2015
Q4 		$5.58M Buy
2,276,923
+70,659
+3% +$202K 0.05% 395
2015
Q3 		$6.62M Sell
2,206,264
-1,257,541
-36% -$5.43M 0.05% 381
2015
Q2 		$14.3M Sell
3,463,805
-3,104,195
-47% -$12.4M 0.1% 265
2015
Q1 		$28.4M Buy
6,568,000
+3,068,000
+88% +$11.1M 0.19% 155
2014
Q4 		$10.4M Buy
+3,500,000
New +$9.6M 0.07% 319

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steven Cohen's CPRX Position: Q2 2026 in Review

Steven Cohen reduced its Catalyst Pharmaceutical (CPRX) stake by 59% in Q2 2026, selling an estimated $7.36M and leaving 176,560 shares worth $5.55M. The position accounts for 0.01% of the portfolio, ranked #1689.

Steven Cohen first reported a position in CPRX in Q4 2014 and has held it in 18 quarters since. The position peaked at $28.4M in Q1 2015. 392 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Steven Cohen held 176,560 shares of Catalyst Pharmaceutical worth $5.55M as of Q2 2026.
  • Steven Cohen sold 249,305 Catalyst Pharmaceutical shares in Q2 2026, an estimated $7.36M.
  • Catalyst Pharmaceutical made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1689 holding.
  • Steven Cohen first reported a position in Catalyst Pharmaceutical in Q4 2014 and has held it in 18 quarters since.
  • Steven Cohen's Catalyst Pharmaceutical position peaked at $28.4M in Q1 2015.
  • 392 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.